KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) Net Income - Minority (2016 - 2021)

Historic Net Income - Minority for Gilead Sciences (GILD) over the last 11 years, with Q2 2021 value amounting to -$7.0 million.

  • Gilead Sciences' Net Income - Minority rose 9391.3% to -$7.0 million in Q2 2021 from the same period last year, while for Jun 2021 it was -$7.0 million, marking a year-over-year increase of 9391.3%. This contributed to the annual value of -$19.0 million for FY2020, which is 8480.0% up from last year.
  • Per Gilead Sciences' latest filing, its Net Income - Minority stood at -$7.0 million for Q2 2021, which was up 9391.3% from -$12.0 million recorded in Q1 2021.
  • In the past 5 years, Gilead Sciences' Net Income - Minority registered a high of -$7.0 million during Q2 2021, and its lowest value of -$476.0 million during Q1 2017.
  • Its 5-year average for Net Income - Minority is -$144.2 million, with a median of -$120.0 million in 2019.
  • Its Net Income - Minority has fluctuated over the past 5 years, first crashed by 14915.25% in 2018, then skyrocketed by 9391.3% in 2021.
  • Over the past 5 years, Gilead Sciences' Net Income - Minority (Quarter) stood at -$59.0 million in 2017, then tumbled by 149.15% to -$147.0 million in 2018, then grew by 14.97% to -$125.0 million in 2019, then skyrocketed by 84.8% to -$19.0 million in 2020, then skyrocketed by 63.16% to -$7.0 million in 2021.
  • Its Net Income - Minority stands at -$7.0 million for Q2 2021, versus -$12.0 million for Q1 2021 and -$19.0 million for Q4 2020.